BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38542414)

  • 41. Evaluation of Clinical Significance of Lymphovascular Space Invasion in Stage IA Endometrial Cancer.
    Okugawa K; Yahata H; Hachisuga K; Tomonobe H; Yasutake N; Kodama K; Kenjo H; Yagi H; Ohgami T; Yasunaga M; Onoyama I; Asanoma K; Hori E; Ohishi Y; Oda Y; Kato K
    Oncology; 2022; 100(4):195-202. PubMed ID: 34915516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature.
    Raffone A; Travaglino A; Raimondo D; Neola D; Maletta M; Santoro A; Insabato L; Casadio P; Fanfani F; Zannoni GF; Zullo F; Seracchioli R; Mollo A
    Gynecol Oncol; 2022 Apr; 165(1):192-197. PubMed ID: 35078650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defining Substantial Lymphovascular Space Invasion in Endometrial Cancer.
    Peters EEM; León-Castillo A; Smit VTHBM; Boennelycke M; Hogdall E; Hogdall C; Creutzberg C; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JWM; Lutgens LCHW; van der Steen-Banasik EM; Ortoft G; Bosse T; Nout R
    Int J Gynecol Pathol; 2022 May; 41(3):220-226. PubMed ID: 34261899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of tumor grade and lymphovascular space invasion in endometrial adenocarcinoma with MR imaging-based radiomic analysis.
    Bereby-Kahane M; Dautry R; Matzner-Lober E; Cornelis F; Sebbag-Sfez D; Place V; Mezzadri M; Soyer P; Dohan A
    Diagn Interv Imaging; 2020 Jun; 101(6):401-411. PubMed ID: 32037289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lower uterine segment involvement in lymphovascular space invasion and lymph node metastasis in endometrioid endometrial cancer.
    Cokmez H; Yilmaz A
    Ginekol Pol; 2019; 90(6):314-319. PubMed ID: 31276182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The grading of lymphovascular space invasion in epithelial ovarian carcinoma.
    Qian X; Xi X; Jin Y
    Int J Gynecol Cancer; 2010 Jul; 20(5):895-9. PubMed ID: 20606540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.
    Bosse T; Peters EE; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Mens JW; Lutgens LC; van der Steen-Banasik EM; Smit VT; Nout RA
    Eur J Cancer; 2015 Sep; 51(13):1742-50. PubMed ID: 26049688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy.
    Narayan K; Khaw P; Bernshaw D; Mileshkin L; Kondalsamy-Chennakesavan S
    Int J Gynecol Cancer; 2012 Feb; 22(2):260-6. PubMed ID: 22080878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma.
    Sakuragi N; Hareyama H; Todo Y; Yamada H; Yamamoto R; Fujino T; Sagawa T; Fujimoto S
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):311-6. PubMed ID: 10746848
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The grading of lymphovascular space invasion in endometrial carcinoma.
    Hachisuga T; Kaku T; Fukuda K; Eguchi F; Emoto M; Kamura T; Iwasaka T; Kawarabayashi T; Sugimori H; Mori M
    Cancer; 1999 Nov; 86(10):2090-7. PubMed ID: 10570436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A clinical marker-based modeling framework to preoperatively predict lymph node and vascular space involvement in endometrial cancer patients.
    Miller HA; Tran A; LyBarger KS; Frieboes HB
    Eur J Surg Oncol; 2024 Jan; 50(1):107309. PubMed ID: 38056021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does the type of surgery for early-stage endometrial cancer affect the rate of reported lymphovascular space invasion in final pathology specimens?
    Momeni M; Kolev V; Cardenas-Goicoechea J; Getrajdman J; Fishman D; Chuang L; Kalir T; Rahaman J; Zakashansky K
    Am J Obstet Gynecol; 2013 Jan; 208(1):71.e1-6. PubMed ID: 23099190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-Risk Endometrial Cancer.
    Peters EEM; Léon-Castillo A; Hogdall E; Boennelycke M; Smit VTHBM; Hogdall C; Creutzberg CL; Bosse T; Nout RA; Ørtoft G
    Int J Gynecol Pathol; 2022 May; 41(3):227-234. PubMed ID: 34392268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic significance of lymphovascular space invasion in patients with endometrioid endometrial cancer: a retrospective study from a single center.
    Dai Y; Dong Y; Cheng Y; Hou H; Wang J; Wang Z; Wang J
    J Gynecol Oncol; 2020 May; 31(3):e27. PubMed ID: 31912681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma.
    Zhang C; Wang C; Feng W
    Int J Gynecol Cancer; 2012 Oct; 22(8):1373-7. PubMed ID: 22932266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of lymphovascular space invasion in early-stage cervical cancer.
    Weyl A; Illac C; Lusque A; Leray H; Vaysse C; Martinez A; Chantalat E; Motton S
    Int J Gynecol Cancer; 2020 Oct; 30(10):1493-1499. PubMed ID: 32565486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic Value of β-Catenin and L1CAM Expressions in Type I Endometrial Carcinoma.
    Manule Y; Miskad UA; Masadah R; Nelwan B; Cangara MH; Mardiati M
    Asian Pac J Cancer Prev; 2023 Apr; 24(4):1413-1417. PubMed ID: 37116166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expressions in type 2 endometrial cancer.
    Kucukgoz Gulec U; Kilic Bagir E; Paydas S; Guzel AB; Gumurdulu D; Vardar MA
    Arch Gynecol Obstet; 2019 Aug; 300(2):377-382. PubMed ID: 31076855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymphovascular space invasion in robotic surgery for endometrial cancer.
    Hopkins MR; Richmond AM; Cheng G; Davidson S; Spillman MA; Sheeder J; Post MD; Guntupalli SR
    JSLS; 2014; 18(3):. PubMed ID: 25392608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.